Repligen to Report Fourth Quarter and Full Year 2025 Financial Results

Core Viewpoint - Repligen Corporation will report its fourth quarter 2025 financial results on February 24, 2026, with a conference call scheduled for 8:30 a.m. ET to discuss the results and business updates [1]. Group 1: Financial Reporting - The financial results will cover the three- and twelve-month periods ending December 31, 2025 [1]. - A press release will be issued before the market opens on the reporting date [1]. Group 2: Conference Call Details - The conference call can be accessed by domestic callers at toll-free number (800) 715-9871 and international callers at (646) 307-1963, with no passcode required [2]. - A webcast of the conference call will be available on the Investor Relations section of the company's website, and both the call and webcast will be archived for later access [2]. Group 3: Company Overview - Repligen Corporation is a global life sciences company focused on developing and commercializing innovative bioprocessing technologies for the manufacturing of biological drugs [3]. - The company serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide, with a focus on areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3]. - The corporate headquarters is located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3].